[VIVO] QoQ Quarter Result on 30-Sep-2021 [#Q4]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
23-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q4]
Profit Trend
QoQ- -42.95%
YoY- 2.53%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 67,771 111,231 88,341 76,204 63,511 85,264 92,917 -19.01%
PBT -6,602 36,535 19,751 7,856 15,295 33,052 34,248 -
Tax 736 7,783 4,411 1,199 3,626 6,750 7 2146.75%
NP -7,338 28,752 15,340 6,657 11,669 26,302 26,779 -
Tax Rate - -21.30% -22.33% -15.26% -23.71% -20.42% -0.02% -
Total Cost 75,109 82,479 73,001 69,547 51,842 58,962 66,138 8.87%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -10.83 25.85 17.36 8.74 18.37 30.85 28.82 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.16 0.65 0.35 0.15 0.27 0.61 0.62 -
EPS Diluted -0.16 0.65 0.35 0.15 0.26 0.60 0.61 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.